BRD7116

CAS : 329059-55-4

Ref. 3D-ENA05955

Informations sur le produit

• Nom: BRD7116
• Marque: Biosynth
• Description: BRD7116 is an anilide that targets leukemia stem cells and has shown to be effective in the treatment of leukemic patients. BRD7116 has been shown to inhibit proliferation and induce apoptosis in leukemia stem cells, which is a promising therapeutic approach for leukemia. The high-throughput screening assay was used to identify BRD7116 as a potential candidate for the treatment of this disease. This compound inhibits the growth of leukemic stem cells by downregulating proteins essential for cell cycle progression, including CDK2, cyclin D1, and Bcl-2.

Propriétés chimiques

• Masse moléculaire: 496.66 g/mol
• Formule: C₂₈H₃₆N₂O₄S
• Degré de pureté: Min. 95%